Free Nonvascularized Fibula Autograft for Tumor-like Lesions in Femoral Neck Using in Pediatric Patients

Not Applicable

Completed

• Conditions: Bone Diseases
• Interventions: Procedure: free nonvascularized fibula autograft

• Registration Number: NCT03129230
• Lead Sponsor: Yulin Orthopedics Hospital of Chinese and Western Medicine

Brief Summary

This study was to evaluate the safety and efficacy of free nonvascularized fibula autograft in the treatment of the femoral neck tumor-like lesions before epiphyseal closure in pediatric patients, by presenting the clinic-radiological outcome and complications.

Detailed Description

Not available

Study Timeline

• Study Start: 2012-08-01
• Primary Completion: 2016-09-01
• Study Completion: 2017-03-01
• Study First Submitted: 2017-04-05
• Study First Submitted QC: 2017-04-22
• Study First Posted: 2017-04-26
• Status Verified: 2018-11
• Last Update Submitted: 2018-11-25
• Last Update Posted: 2018-11-27

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 16

Inclusion Criteria

1. This retrospective study included pediatric patients before epiphyseal closure with tumor-like lesions in femoral neck.

Exclusion Criteria

1. pediatric patients with tumor-like lesions in femoral neck after epiphyseal closure;
2. pediatric patients with benign bone tumors and malignant bone tumors in the femoral neck after epiphyseal closure;
3. adult patients with benign or malignant bone tumors and tumor-like lesions in femoral neck.

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: SINGLE_GROUP

Arm && Interventions

Group	Intervention	Description
Free nonvascularized fibula autograft	free nonvascularized fibula autograft	Sixteen pediatric patients before epiphyseal closure were treated with free nonvascularized fibula autograft after resections of tumor-like lesions in the femoral neck.

Primary Outcome Measures

Name	Time	Method
change of peri-implant bone level from baseline at 7 and 54 months	7 months to 54 months	Mean follow-up of all the patients after primary surgery was 24 months, ranged 7 months to 54 months.

Trial Locations

Locations (2)

Yulin Orthopedics Hospital of Chinese and Western Medicine; 🇨🇳 Yulin, Guangxi, China

The First Affiliated Hospital of Guangxi Medical University; 🇨🇳 Nanning, Guangxi, China